Putting the Pieces Together Perspectives from an Opioid Addiction Treatment Program.

Slides:



Advertisements
Similar presentations
Children, Families & Substance Abuse Impact and Treatment.
Advertisements

One Science = Early Childhood Pathway for Healthy Child Development Sentinel Outcomes ALL CHILDREN ARE BORN HEALTHY measured by: rate of infant mortality.
Benchmark: Improved Maternal and Newborn Health Construct: Prenatal care Parental use of alcohol, tobacco, or illicit drugs Preconception care Inter-birth.
Treatment Alternatives to Prison A Health Impact Assessment Scope of research February 2012 Health Impact Assessment – a structured yet flexible research.
13 Principles of Effective Addictions Treatment
Part A/Module A1/Session 4 Part A: Module A1 Session 4 Comprehensive Care for People Living with HIV/AIDS (PLHA)
Effective Risk Management Strategies in Outpatient Methadone Treatment: Clinical Guidelines and Liability Prevention Curriculum Module 9 Special Populations.
Fact sheet Policies and Programs to Address Drug-Exposed Newborns The use or abuse of either illegal or prescription drugs during pregnancy can have serious.
Models of Evaluation of Addiction Treatment Outcome Post-Treatment vs. During Treatment Evaluation of Effectiveness.
Treatment of opioid dependence during pregnancy Judith Martin, MD Medical Director The 14 th Street Clinic, Oakland
Pharmacological Treatment of Opioid Dependence during Pregnancy: Methadone and Buprenorphine Overview Karol Kaltenbach, PhD Maternal Addiction Treatment.
Integrated Dual Diagnosis Treatment
Principles of Drug Addiction Treatment: What Works with Offenders? Rita Dries July 2006.
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, Deputy Director Andrea Boxill, Deputy Director Governor’s Cabinet Opiate Action Team.
Chapter Objectives Define maternal, infant, and child health.
Understanding Drug Abuse and Addiction: What Science Says Developed by the National Institute on Drug Abuse (NIDA) National Institutes of Health Bethesda,
Diagnosis And Treatment Of Prescription Opioid Dependence Steven W. Clay, D.O. Associate Professor, Department of Family Medicine Ohio University College.
Psychopharmacotherapy in Correctional Institutions Robert P. Schwartz, M.D. Friends Research Institute Supported by NIDA R01 DA (PI: Kinlock)
Amethyst, Inc. Amethyst exists to nurture and sustain healthy women and families. We have been providing gender specific and trauma informed alcohol, tobacco.
Medication Assisted Treatment (MAT) Issues for Women Susan F. Neshin, MD Medical Director JSAS Healthcare, Inc. Asbury Park, NJ
Practical Application of Contingency Management Michael J. McCann, MA Matrix Institute on Addictions.
SUBSTANCE USE DISORDERS GENERAL METHODS OF TREATMENT Inpatient Detoxification and Rehabilitation Outpatient Individual, Couple, or Family Counseling Self-help.
Research and Health Utilization Around Conduct Problems Scott T. Ronis, Ph.D. Department of Psychology University of New Brunswick ________________________________________.
Attractive Addiction Treatment...? Can we make addiction treatment engaging?
© CDHS/Research Foundation of SUNY/BSC College Relations Group Women with Substance Abuse & Trauma Related Psychiatric Problems Resource Manual.
Ramey & Ramey (1998) Early Intervention: activities designed to enhance a young child’s development Initial evaluation of child’s abilities and needs (in.
For more information contact Alemi at
BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS Module III – Buprenorphine 101.
Disaster and Trauma During Childhood: The Role of Clinicians Stephen J. Cozza, M.D. Professor of Psychiatry Uniformed Services University.
Medication Assisted Therapy for Opioid Addiction: Methadone and Buprenorphine Andrew J. Saxon, M.D. Veterans Affairs Puget Sound Health Care System and.
Good Prescribing to support Criminal Justice Interventions
OPIOID SUBSTITUTION THERAPY
Chapter 10 Counseling At Risk Children and Adolescents.
Mission: Protect the Vulnerable, Promote Strong and Economically Self- Sufficient Families, and Advance Personal and Family Recovery and Resiliency. Charlie.
Substance Use & Abuse in Pregnancy Janet L. Mitchell, M.D., M.P.H., F.A.C.O.G. Consultant on Women’s Health Addiction Research & Treatment Corporation.
Pregnancy and Drug Abuse Eva Janecek-Rucker. Learning Objectives 1.To develop a knowledge base of the effects of substances of abuse (e.g., alcohol, cocaine,
Module IV: Identification of Patients for Buprenorphine Treatment BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals.
Medical issues about Methadone : What the counselor needs to know
1 Care for Injection Drug Users (IDUs) with HIV HAIVN Havard Medical School AIDS Initiative in Vietnam.
Chapter 16 Addictive Disorders. Abuse  Use of a substance that falls outside of medical necessity or social acceptance resulting in adverse effects to.
Raymond F. Anton, MD for The COMBINE Study Research Group
The COMBINE Study: Design and Methodology Stephanie S. O’Malley, Ph.D. for The COMBINE Study Research Group JAMA Vol. 295, , 2006 (May 3 rd.
The Counseling Center, Inc. Devoted to the prevention and treatment of alcoholism and other drug addictions. We promote opportunities for individuals and.
Table 1. Prediction model for maximum daily dose of buprenorphine-naloxone in a 12-week treatment condition Baseline Predictors Maximum Daily Dose Standardized.
Special patient groups Module 5. Introduction Worldwide, the majority of people in substitute treatment are men between Even they do not form a.
TREATMENT OF SUBSTANCE USE DISORDERS TX myths 1. Nothing works 2. One approach is superior to all others (“one true light” tradition) 3. All treatment.
Module IV - Identification of Patients for Buprenorphine Treatment BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS.
Ten Years of Pharmacotherapy Trials in the CTN: An Overview.
Principles of Effective Drug Addiction Treatment Health 10 The Truth About Drugs Ms. Meade.
Understanding Drug Abuse and Addiction: What Science Says Developed by the National Institute on Drug Abuse (NIDA) National Institutes of Health Bethesda,
Buprenorphine {Suboxone®, Subutex®}
Medication Assisted Treatment for Opioid Use Disorders
Trends in Access to Substance Abuse Treatment for Women and Men: Jeanne C. Marsh, PhD, Hee-Choon Shin, PhD, Dingcai Cao, PhD University of Chicago.
SUBSTANCE ABUSE prevention
Suboxone and Opioid Trends Joseph Merrill M.D., M.P.H. University of Washington June 16, 2009.
Substance Exposed Newborns: Addressing Substance Use Disorder
Current Concepts in Pain Management
US Census Data Ortman, Jennifer M., Victoria A. Velkoff, and Howard Hogan. An Aging Nation: The Older Population in the United States, Current Population.
Drugs and Neuron Communication
Opioid Use Disorder and pregnancy seminar
COLLECTIVE IMPACT APPROACH TO ADDRESSING
Parent-Child Assistance Program (PCAP) 1991-present An intensive 3-year home visitation intervention for pregnant and parenting, alcohol/drug abusing.
Addressing dual diagnosis within a residential treatment programme serving women with complex needs Anita Harris.
The Opioid Crisis: What Can Be Done for the Children
Reducing Heavy Drinking to Optimize HIV/AIDS Treatment and Prevention
Women’s Treatment and Resources
Medication Assisted Treatment: Changing the Trajectory of the Opioid Epidemic
Medication Assisted Treatment of Opioid Use Disorder
Treating and Managing Opioid Use Disorder in Pregnancy
PSYCHOPATHOLOGY OF CHILDREN AND FAMILY
Presentation transcript:

Putting the Pieces Together Perspectives from an Opioid Addiction Treatment Program

Participants will learn: Basic principles of treatment of opioid addiction and polysubstance abuse The complexities of treating substance abusing parents Strategies for addressing the specific needs of families in substance abuse treatment.

O pioid Addiction Treatment: An Overview Theories of Addiction Treatment of Opioid Dependency Impact of Opioid Agonist Treatment Treatment of other drugs of abuse Pregnancy and Treatment

Theories of Addiction Medical Psychological Environmental Moral

Medical Model Disease Neurological processes Other systems affected Impact on behaviors Long term neurological implications Benefits of medication-assisted treatment

BASICS OF MEDICATION- ASSISTED THERAPY FOR OPIOID DEPENDENCE

GOALS OF TREATMENT: Retention in treatment Reduction in drug use Prevention of relapse Restoration of quality of life 7

Opioid Agonist Therapy Most effective treatment for heroin or other opioid dependence Targets the major biologic factors perpetuating opioid addiction Steady-state opioid maintenance prevents withdrawal and relieves craving for opioids (cross- tolerance) Euphoric effects of heroin are blocked or attenuated (narcotic blockade)

Dose Response Time “Loaded” “High” Normal Range “Comfort Zone” “Sick” Impact of Heroin on an Individual Tolerant to Opioids 0 hrs.24 hrs. Subjective withdrawal PAYTE: Opioid Maintenance Pharmacotherapy - A Course for Clinicians 9

Methadone: An Effective Treatment for Opioid Dependency - Reduces heroin use. - Reduces relapse. - Reduces rate of HIV seroconversion. - Reduces criminal activity. - Improves employment. - Improves physical and mental health.

Dose Response Time “Loaded” “High” Normal Range “Comfort Zone” “Sick” Methadone Simulated 24 Hr. Dose/Response At steady-state in tolerant patient 0 hrs.24 hrs. Subjective withdrawal PAYTE: Opioid Maintenance Pharmacotherapy - A Course for Clinicians 11

12 Common Questions in Methadone Maintenance Treatment How much methadone is enough? How long should methadone treatment last? Is the medication alone enough to improve treatment outcomes?

Methadone: Determining Doses Methadone dose affects therapeutic efficacy Considerable variability in treatment practices, including doses (D’Aunno, 1992) Higher doses have been associated with treatment retention and decreased use of illicit drugs

Methadone Dosing Strain, 1993: 247 patients entering methadone maintenance 20 week randomized clinical trial – weeks 0-5: all received active methadone – weeks 6-20: one of three doses DoseUrine toxicology (+)Retention 0 mg74% 21% 20 mg67% 41% 50 mg56% 52%

Methadone Dosing Strain, 1999: 40 week randomized clinical trial 192 patients entering methadone maintenance – dose: moderate (40-50 mg) vs. high ( mg) – results (opioid-positive urine samples during maintenance): moderate: 62% high: 53% (p<.05)

Impact of Methadone Dosing on Heroin Use Strain, 1999

Methadone Dosing Issues How to decide the correct dose of methadone? - prevent withdrawal and craving - provide cross-tolerance - reduce drug use - account for medication interactions - consider psychiatric and medical co-morbidity Patient preferences affect dosing: - stigma: “I’m not such a bad junkie.” - fears of withdrawal from methadone

Methadone Maintenance: Counseling and Supportive Services Matter McLellan et al., 1993: – 6-month randomized clinical trial – three levels of psychological services methadone alone methadone plus standard counseling services methadone plus enhanced services (counseling, medical/psychiatric, employment, and family therapy)

Methadone Alone is not Sufficient to Achieve Full Benefit: Counseling Matters 55%28%0% >16 consecutive weeks of (-) urines 81%59%31% Methadone + Enhanced Counseling Methadone + Std. CounselingMethadoneOutcome Retention

Time in Treatment Longer treatment time associated with improved outcomes. No one right time “Indefinite” Limited capacity to predict who is likely to relapse

Buprenorphine: Another Option for Treating Opioid Dependence Available in primary care settings, not exclusively in drug treatment facilities. Partial agonist properties may affect its utility in some patients. Appears to have equivalent effectiveness as methadone in many patients. Not FDA-approved for treating pregnant women.

Issues for Opioid Dependent Pregnant Women

Methadone maintenance therapy in combination with counseling, comprehensive services (including prenatal care): – reduces the incidence of obstetric complications – reduces neonatal morbidity and mortality (Finnegan, 1991) Methadone Maintenance Treatment is Effective for Pregnant Women

Methadone Dosing During Pregnancy Patients receiving methadone maintenance therapy who become pregnant can be continued at established dose. Physiologic change during pregnancy can lead to increased methadone maintenance dose requirements, especially during 3rd trimester.

Implications for Newborns born to Methadone-Maintained Mothers Breast-feeding is not contraindicated, unless the mother is using illicit drugs or is infected with HIV. Methadone-exposed infants develop comparably to infants born in similar socioeconomic circumstances.

What about other drugs? Alcohol abuse and dependency Cocaine abuse and dependency Prescription drug misuse

Using toxicology reports Error rates What do the reports mean? Patterns of use/abuse Other signs Client progress – ability to keep appointments Motivation to treatment Reports from other sources - collaboration

Comprehensive outpatient treatment services includes : Substance Abuse Counseling!!! Primary medical care Arrangements for concrete service needs (housing, food, clothing) Mental health services Vocational services Family counseling Legal services Interdisciplinary approach Collaboration

Characteristics of Substance Abusing Families Studies of addicted women reveal: – Feelings of low self ‑ esteem Family histories of drug ‑ using parents reflect: – Disruption – Conflict/domestic violence/incest – Loss of parental figures – Lack of strong affectionate parent ‑ child bonds. – Addiction – Post traumatic stress disorder – Anxiety – Depression – Guilt over affects on their children The childhood experiences of drug ‑ abusing women can be characterized by maternal deprivation, lack of supportive family networks, and maltreatment.

Services to families in addiction treatment Many approach parenthood with minimal bonding experience, unrealistic expectations and without having learned adequate parenting skills. Substance abuse is not only the problem of the individual but must be considered in the context of family. What can be done?

Treatment as prevention of foster care placement Family Counseling Parenting Skills classes Parent Support Groups Child Care Services Domestic Violence services Staff training

And in coordination with child welfare and dependency courts: Facilitation of case resolution Support for family reunification Effective intervention

What do treatment providers need to accomplish this? Confidentiality Collaboration and coordination Meeting the demands of multiple agencies

CASES FOR DISCUSSION

Risk of Leaving Treatment Relative to Dose 80 + mg mg < 60 mg (Baseline) Adapted from Caplehorn & Bell - The Medical Journal of Australia PAYTE: Opioid Maintenance Pharmacotherapy - A Course for Clinicians 35